Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1990 5
1991 5
1992 8
1993 8
1994 11
1995 10
1996 13
1997 12
1998 12
1999 13
2000 12
2001 19
2002 15
2003 19
2004 16
2005 15
2006 25
2007 20
2008 26
2009 27
2010 22
2011 23
2012 24
2013 29
2014 31
2015 26
2016 27
2017 26
2018 34
2019 34
2020 29
2021 24
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

578 results
Results by year
Filters applied: . Clear all
Page 1
Proton-Sensing GPCRs in Health and Disease.
Sisignano M, Fischer MJM, Geisslinger G. Sisignano M, et al. Among authors: geisslinger g. Cells. 2021 Aug 10;10(8):2050. doi: 10.3390/cells10082050. Cells. 2021. PMID: 34440817 Free PMC article. Review.
Pharmacokinetics of non-intravenous formulations of fentanyl.
Lötsch J, Walter C, Parnham MJ, Oertel BG, Geisslinger G. Lötsch J, et al. Among authors: geisslinger g. Clin Pharmacokinet. 2013 Jan;52(1):23-36. doi: 10.1007/s40262-012-0016-7. Clin Pharmacokinet. 2013. PMID: 23100195 Review.
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
Krasemann S, Haferkamp U, Pfefferle S, Woo MS, Heinrich F, Schweizer M, Appelt-Menzel A, Cubukova A, Barenberg J, Leu J, Hartmann K, Thies E, Littau JL, Sepulveda-Falla D, Zhang L, Ton K, Liang Y, Matschke J, Ricklefs F, Sauvigny T, Sperhake J, Fitzek A, Gerhartl A, Brachner A, Geiger N, König EM, Bodem J, Franzenburg S, Franke A, Moese S, Müller FJ, Geisslinger G, Claussen C, Kannt A, Zaliani A, Gribbon P, Ondruschka B, Neuhaus W, Friese MA, Glatzel M, Pless O. Krasemann S, et al. Among authors: geisslinger g. Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20. Stem Cell Reports. 2022. PMID: 35063125 Free PMC article.
Ceramides as Novel Disease Biomarkers.
Kurz J, Parnham MJ, Geisslinger G, Schiffmann S. Kurz J, et al. Among authors: geisslinger g. Trends Mol Med. 2019 Jan;25(1):20-32. doi: 10.1016/j.molmed.2018.10.009. Epub 2018 Nov 23. Trends Mol Med. 2019. PMID: 30477968 Review.
Drugging the pain epigenome.
Niederberger E, Resch E, Parnham MJ, Geisslinger G. Niederberger E, et al. Among authors: geisslinger g. Nat Rev Neurol. 2017 Jul;13(7):434-447. doi: 10.1038/nrneurol.2017.68. Epub 2017 May 26. Nat Rev Neurol. 2017. PMID: 28548108 Review.
Novel Approaches to Persistent Pain Therapy.
Sisignano M, Parnham MJ, Geisslinger G. Sisignano M, et al. Among authors: geisslinger g. Trends Pharmacol Sci. 2019 Jun;40(6):367-377. doi: 10.1016/j.tips.2019.04.003. Epub 2019 May 8. Trends Pharmacol Sci. 2019. PMID: 31078322 Review.
The immunomodulatory potential of the arylmethylaminosteroid sc1o.
Blum L, Ulshöfer T, Henke M, Krieg R, Berneburg I, Geisslinger G, Becker K, Parnham MJ, Schiffmann S. Blum L, et al. Among authors: geisslinger g. J Mol Med (Berl). 2021 Feb;99(2):261-272. doi: 10.1007/s00109-020-02024-4. Epub 2020 Dec 17. J Mol Med (Berl). 2021. PMID: 33330947 Free PMC article.
Proteomics and NF-κB: an update.
Niederberger E, Geisslinger G. Niederberger E, et al. Among authors: geisslinger g. Expert Rev Proteomics. 2013 Apr;10(2):189-204. doi: 10.1586/epr.13.5. Expert Rev Proteomics. 2013. PMID: 23573785 Review.
578 results